Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,169 | 70 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $360.04 | 23 | $0 (2024) |
| Novo Nordisk Inc | $270.86 | 12 | $0 (2024) |
| PFIZER INC. | $147.86 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $94.84 | 6 | $0 (2024) |
| Amgen Inc. | $58.61 | 4 | $0 (2024) |
| ABBVIE INC. | $51.04 | 3 | $0 (2023) |
| Phathom Pharmaceuticals, Inc. | $31.61 | 2 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $31.18 | 2 | $0 (2021) |
| IDORSIA PHARMACEUTICALS US INC | $30.48 | 2 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $26.91 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $465.19 | 29 | Lilly USA, LLC ($188.36) |
| 2023 | $240.40 | 15 | Lilly USA, LLC ($86.02) |
| 2022 | $237.79 | 16 | PFIZER INC. ($74.42) |
| 2021 | $225.51 | 10 | Novo Nordisk Inc ($141.14) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Gastroenterology | ||||||
| 10/30/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Inflammation | ||||||
| 09/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Oncology | ||||||
| 09/05/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Respiratory | ||||||
| 08/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Obesity | ||||||
| 08/04/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $10.05 | General |
| Category: Diabetes | ||||||
| 07/11/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Diabetes | ||||||
| 06/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/20/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Obesity | ||||||
| 06/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Diabetes | ||||||
| 06/04/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Diabetes | ||||||
| 05/08/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Insomnia | ||||||
| 05/02/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/01/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: NEUROSCIENCE | ||||||
| 04/18/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Obesity | ||||||
| 04/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Diabetes | ||||||
| 04/08/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Diabetes | ||||||
| 04/04/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Diabetes | ||||||
| 03/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Respiratory | ||||||
| 03/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 2,385 | 3,219 | $181,993 | $100,190 |
| 2022 | 32 | 2,620 | 4,062 | $196,011 | $98,325 |
| 2021 | 44 | 3,313 | 4,800 | $257,400 | $135,779 |
| 2020 | 16 | 594 | 978 | $37,552 | $16,470 |
All Medicare Procedures & Services
126 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 307 | 307 | $43,901 | $31,111 | 70.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 309 | 311 | $32,655 | $20,045 | 61.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 240 | 369 | $36,900 | $19,164 | 51.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 169 | 187 | $26,180 | $12,883 | 49.2% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 60 | 65 | $5,200 | $2,636 | 50.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 108 | 115 | $3,450 | $1,509 | 43.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 151 | 178 | $1,780 | $1,495 | 84.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 127 | 141 | $3,525 | $1,449 | 41.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 140 | 154 | $3,388 | $1,157 | 34.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 15 | 15 | $1,125 | $1,079 | 95.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 51 | 54 | $2,160 | $888.84 | 41.2% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 20 | 25 | $1,500 | $868.00 | 57.9% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 17 | 34 | $850.00 | $551.48 | 64.9% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 33 | 35 | $770.00 | $550.80 | 71.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 51 | 64 | $1,920 | $543.75 | 28.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 51 | 56 | $1,680 | $533.12 | 31.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 16 | 16 | $560.00 | $456.00 | 81.4% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 29 | 30 | $1,350 | $443.40 | 32.8% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 46 | 48 | $1,920 | $424.32 | 22.1% |
| 82306 | Vitamin d-3 level | Office | 2023 | 12 | 12 | $660.00 | $348.12 | 52.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 130 | 146 | $1,460 | $316.80 | 21.7% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 17 | 19 | $905.00 | $299.76 | 33.1% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 16 | 17 | $510.00 | $227.12 | 44.5% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 11 | 11 | $440.00 | $208.12 | 47.3% |
| 83540 | Iron level | Office | 2023 | 23 | 25 | $375.00 | $158.50 | 42.3% |
About Anna James, NP
Anna James, NP is a Family healthcare provider based in Tuscumbia, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2020. The National Provider Identifier (NPI) number assigned to this provider is 1144839069.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Anna James, NP has received a total of $1,169 in payments from pharmaceutical and medical device companies, with $465.19 received in 2024. These payments were reported across 70 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,169).
As a Medicare-enrolled provider, James has provided services to 8,912 Medicare beneficiaries, totaling 13,059 services with total Medicare billing of $350,764. Data is available for 4 years (2020–2023), covering 126 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Tuscumbia, AL
- Active Since 07/27/2020
- Last Updated 07/27/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1144839069
Products in Payments
- MOUNJARO (Drug) $240.70
- Ozempic (Drug) $122.70
- RYBELSUS (Drug) $98.84
- ELIQUIS (Drug) $90.85
- FARXIGA (Drug) $65.73
- Otezla (Drug) $58.61
- ZEPBOUND (Drug) $58.47
- PREVNAR 20 (Biological) $42.56
- VRAYLAR (Drug) $36.38
- VOQUEZNA (Drug) $31.61
- TRULICITY (Drug) $30.59
- QUVIVIQ (Drug) $30.48
- JARDIANCE (Drug) $30.28
- BREZTRI (Drug) $29.11
- XIFAXAN (Drug) $21.39
- Wegovy (Drug) $18.72
- TRINTELLIX (Drug) $17.51
- Saxenda (Drug) $16.41
- GARDASIL 9 (Biological) $16.12
- PNEUMOVAX 23 (Biological) $15.06
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Tuscumbia
Susanna Hall, Fnp, FNP
Family — Payments: $1,266
Anita Mcdonald, Crnp, CRNP
Family — Payments: $1,258
Alicia Nix, Np, NP
Family — Payments: $601.02
Mrs. Brandi Jackson, Crnp, CRNP
Family — Payments: $259.21
Meggin Tallman, Crnp, CRNP
Family — Payments: $230.89
Lindsay Humphreys, Fnp-C, FNP-C
Family — Payments: $212.57